IPP Protein, Human (sf9)
IPP may organize the actin cytoskeleton, affecting the structural arrangement and dynamics of the cell's cytoskeletal network. It contributes to the organization of actin filaments, which is critical for cell morphology, movement and signaling. IPP Protein, Human (sf9) is the recombinant human-derived IPP protein, expressed by sf9 insect cells , with tag free.
- Species: Human
- Source: Sf9 insect cells
Biological Activity
IPP may organize the actin cytoskeleton, affecting the structural arrangement and dynamics of the cell's cytoskeletal network. It contributes to the organization of actin filaments, which is critical for cell morphology, movement and signaling. IPP Protein, Human (sf9) is the recombinant human-derived IPP protein, expressed by sf9 insect cells , with tag free.
The IPP protein is implicated in potentially playing a role in organizing the actin cytoskeleton, indicating its involvement in the structural arrangement and dynamics of the cellular cytoskeletal network. Functionally, IPP is suggested to contribute to the organization of actin filaments, which are essential for various cellular processes, including cell morphology, motility, and intracellular signaling. The specific mechanisms by which IPP orchestrates actin cytoskeleton organization remain areas of interest, warranting further exploration to elucidate its functional significance and molecular interactions in the intricate regulation of cellular architecture and dynamics.
Technical Parameters
-
Species Human
-
Source Sf9 insect cells
-
Tag Tag Free
-
Accession
Q9Y573 (A2-L584)
-
Gene ID3652
-
Molecular Construction
-
N-term
-
IPP (A2-L584)
Accession # Q9Y573 -
C-term
-
-
Protein Length
Partial
-
Synonyms
IPP; Kelch-Like Family Member 27; Intracisternal A Particle-Promoted Polypeptide; Actin-Binding Protein IPP; KLHL27; Kelch-Like Protein 27
-
AA Sequence
ANEDCPKAADSPFSSDKHAQLILAQINKMRNGQHFCDVQLQVGQESFKAHRLVLAASSPYFAALFTGGMKESSKDVVPILGIEAGIFQILLDFIYTGIVNIGVNNVQELIIAADMLQLTEVVHLCCEFLKGQIDPLNCIGIFQFSEQIACHDLLEFSENYIHVHFLEVHSGEEFLALTKDQLIKILRSEELSIEDEYQVFLAAMQWILKDLGKRRKHVVEVLDPIRFPLLPPQRLLKYIEGVSDFNLRVALQTLLKEYCEVCKSPKENKFCSFLQTSKVRPRKKARKYLYAVGGYTRLQGGRWSDSRALSCVERFDTFSQYWTTVSSLHQARSGLGVTVLGGMVYAIGGEKDSMIFDCTECYDPVTKQWTTVASMNHPRCGLGVCVCYGAIYALGGWVGAEIGNTIERFDPDENKWEVVGNMAVSRYYFGCCEMQGLIYVIGGISNEGIELRSFEVYDPLSKRWSPLPPMGTRRAYLGVAALNDCIYSVGGWNETQDALHTVEKYSFEEEKWVEVASMKVPRAGMCVVAVNGLLYVSGGRSSSHDFLAPGTLDSVEVYNPHSDTWTEIGNMITSRCEGGVAVL
-
Purity
≥ 90%, as determined by reducing SDS-PAGE.
Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)